Market Overview

William Blair Comments On Oracle-MICROS Deal

Share:

Oracle (NASDAQ: ORCL) on Monday announced that it will acquire MICROS Systems (NASDAQ: MCRS) for $68 per share.

In response to the announcement, William Blair analyst Bhavan Suri issued comments regarding the deal. Suri says there are no concerns as to whether or not the $68 per share price represents "enough of a premium" for MICROS.

As a basis for this assertion, Suri cited MICROS' 2014 fiscal growth and pointed out that the hardware refresh for Windows XP is a nonrecurring event.

In conjunction with these comments, Suri has reiterated the Market Perform rating for MICROS. Additionally, MICROS has received downgrades to the equivalent of a Neutral from a number of firms including Wedbush, Northcoast Research and RBC Capital.

Latest Ratings for ORCL

DateFirmActionFromTo
Oct 2019DowngradesBuyHold
Sep 2019MaintainsMarket Perform
Sep 2019MaintainsEqual-Weight

View More Analyst Ratings for ORCL
View the Latest Analyst Ratings

Posted-In: Northcoast Research RBC CapitalAnalyst Color News Downgrades Price Target Reiteration Analyst Ratings

 

Related Articles (MCRS + ORCL)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TOLGoldman SachsInitiates Coverage On42.0
KBHGoldman SachsInitiates Coverage On36.0
YEXTSunTrust Robinson HumphreyMaintains28.0
LHCGSunTrust Robinson HumphreyMaintains160.0
DLRSunTrust Robinson HumphreyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Russia ETFs Hit 5-Month High On Easing Ukraine Tensions

Canaccord Optimistic On IDEXX Laboratories Catalyst One Rollout